Liu, X., Zhao, Y., Zhang, L., Wang, J., Luo, L., Zhang, S., . . . Li, L. ANP32E expression in pancreatic cancer is associated with impaired gemcitabine efficacy and poor patient prognosis. Elsevier.
Chicago Style (17th ed.) CitationLiu, Xiaohong, et al. ANP32E Expression in Pancreatic Cancer Is Associated with Impaired Gemcitabine Efficacy and Poor Patient Prognosis. Elsevier.
MLA (9th ed.) CitationLiu, Xiaohong, et al. ANP32E Expression in Pancreatic Cancer Is Associated with Impaired Gemcitabine Efficacy and Poor Patient Prognosis. Elsevier.
Warning: These citations may not always be 100% accurate.